XML 117 R105.htm IDEA: XBRL DOCUMENT v3.19.2
Earnings Per Common Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Earnings Per Share, Basic and Diluted [Line Items]                      
Income (loss) from continuing operations $ (422) $ 1,390 $ (2,562) $ 998 $ 3,287 $ 1,285 $ 1,097 $ 962 $ (596) $ 6,631 $ 5,320
Income allocated to participating securities                 (3) (24) (27)
Net (income) loss attributable to noncontrolling interests                 2 (1) (2)
Income (loss) from continuing operations attributable to CVS Health                 $ (597) $ 6,606 $ 5,291
Weighted Average Number of Shares Outstanding Reconciliation [Abstract]                      
Weighted average shares, basic (in shares)                 1,044.0 1,020.0 1,073.0
Effect of dilutive securities (in shares)                 0.0 4.0 6.0
Weighted average shares, diluted (in shares)                 1,044.0 1,024.0 1,079.0
Income (loss) from continuing operations attributable to CVS Health (in dollars per share) $ (0.37) $ 1.36 $ (2.52) $ 0.98 $ 3.23 $ 1.26 $ 1.07 $ 0.93 $ (0.57) $ 6.48 $ 4.93
Income (loss) from continuing operations attributable to CVS Health (in dollars per share) $ (0.37) $ 1.36 $ (2.52) $ 0.98 $ 3.22 $ 1.26 $ 1.07 $ 0.92 $ (0.57) $ 6.45 $ 4.91
Employee Stock Option                      
Weighted Average Number of Shares Outstanding Reconciliation [Abstract]                      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)                 13.2 10.4 6.7
Common Equivalent Shares [Member]                      
Weighted Average Number of Shares Outstanding Reconciliation [Abstract]                      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)                 3.0